BLOOMSBURY, NJ, TUESDAY, October 24, 2014 –– Equine NutriceuticalsRx, LLC
invites practicing equine veterinarians to participate in a unique limited-time offer by covering
the cost to run a breakthrough new proinflammatory cytokine diagnostic while trialing The
Winning-Edge™ nutraceutical. Samples will run independently by a designated academic
This offer is only extended to practicing equine veterinarians so they may clinically validate their
patient experiences firsthand with this new and unique nutraceutical. This protocol mirrors data
previously published in a similar study, “The Effect of Exercise and Nutritional Supplementation
on Proinflammatory Cytokine Expression in Young Racehorses During Training.”1
Exciting new diagnostic technology has pioneered the detection and measurement of specific
pre-inflammatory cytokine gene expression in equine and their correlation to inflammation.
Equine athletes exhibit evidence of increased inflammation subsequent to exercise as
characterized by increased expression of mRNA for TNF-α, IL-1β, IL6 along with other
proprietary markers in peripheral blood mononuclear cells.
An increase in inflammatory mediators during training is associated with a failure to adapt to
exercise leading to reduced athletic performance and increased risk to injury. This correlation
has since been validated through testing thousands of horses in ongoing studies.
Equine Nutriceuticals utilized this proinflammatory cytokine technology in a double-blind trial
with 25 Thoroughbred racehorses to assess, “The effect of exercise and nutritional
supplementation on proinflammatory cytokine expression in young racehorses in training.” The
study proved The Winning-Edge nutraceutical had a statistically significant reduction of proinflammatory
mediators. This patented and proprietary supplement contains potent antioxidant
nutrients and anti-inflammatory agents associated with, “An enhanced adaptation to exercise in
terms of a significant reduction in proinflammatory cytokine expression before and after
This limited-time offer gives participating veterinarians the opportunity to personally validate the
clinical evidence demonstrating The Winning-Edge nutraceutical’s benefit of supporting reduced
exercise-induced inflammatory pathologies in horses.
To qualify, veterinarians must agree to treat a minimum of 5 horses with The Winning-Edge
supplement, two (2) packets per day for 1 month, while drawing blood samples pre- and postvigorous
exercise on days 0 and 30. All samples will be sent directly to a leading independent
academic diagnostic lab and the results will be distributed directly from the diagnostic center to
the participating practice. Horses continuing on the supplement after day 30 only require one (1)
packet per day to maintain a healthy pro-inflammatory state.
Dan Kramer, Equine NutriceuticalsRx’s CEO notes, “Our products are only available through
licensed veterinarians with a valid client-patient relationship. This offer is part of our
commitment to support all of our products with evidenced based medicine as documented by
published scientific research.”
To participate in this science based promotion or for more information, please call
844-EQUINE-1 (844-378-4631) or visit the Equine Nutriceuticals’ website at
About Equine NutriceuticalsRx, L.L.C.
Equine NutriceuticalsRx is committed to helping maintain the overall
health and well-being of all horses, companion animals and humans, through
patented and proprietary innovations with preventative and restorative,
nutraceutical ingredient-based, targeted products and programs.
1Horohov. D., et al. The effect of exercise and nutritional supplementation on proinflammatory cytokine
expression in young racehorses during training. JEVS. 2012, Mar 17.